Impact of prostate cancer multifocality on its biology and treatment.

Any focal therapy requires correct localization of the lesion; consequently, much effort is now devoted to accurate characterization of the spatial distribution of the tumor within the prostate. One of the greatest difficulties in the localization of prostate cancer is its frequent multifocality, but prostate cancer is unifocal in 13% to 43.7% of cases and unilateral in 19.2%. In cases of multifocality, it seems that the index tumor is the biologic driving force behind the malignant potential of prostate cancer. Not only is the Gleason score of the secondary nodes lower than that of the index node, but 80% of the secondary nodes are smaller than 0.5 cc and almost all extraprostatic extensions are associated with the largest cancers. While current evaluation with 12 to 18 core biopsies may be adequate to determine the index lesion, transperineal three-dimensional mapping biopsy of the prostate should be undertaken if greater accuracy is needed.

[1]  B. G. Blijenberg,et al.  Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.

[2]  D. Bostwick,et al.  Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Srigley,et al.  Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. , 2009, The Journal of urology.

[4]  V. Mouraviev,et al.  Pathologic basis of focal therapy for early-stage prostate cancer , 2009, Nature Reviews Urology.

[5]  A. Zlotta,et al.  Focal Therapy Will Be the Future Treatment Modality: The Motion ''Con'' , 2009 .

[6]  V. Mouraviev,et al.  Focal Targeted Therapy Will Be a Future Treatment Modality for Early Stage Prostate Cancer , 2009 .

[7]  C. Magi-Galluzzi,et al.  CAN SATURATION BIOPSY PREDICT SIGNIFICANT CANCER NODULE LOCALIZATION IN RADICAL PROSTATECTOMY SPECIMENS: A CORRELATIVE STUDY AND IMPLICATIONS FOR FOCAL THERAPY FOR PROSTATE CANCER , 2009 .

[8]  V. Mouraviev,et al.  Nerve-sparing focal cryoablation of prostate cancer , 2009, Current opinion in urology.

[9]  K. Stamatiou,et al.  The phenomenon of multifocality does not affect the biologic behavior of histologic prostate carcinoma. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[10]  Mark A Rubin,et al.  Evaluating localized prostate cancer and identifying candidates for focal therapy. , 2008, Urology.

[11]  L. Egevad.  Recent trends in gleason grading of prostate cancer. II. Prognosis, reproducibility and reporting. , 2008, Analytical and quantitative cytology and histology.

[12]  J. Moul,et al.  Pathologic stage T2a and T2b prostate cancer in the recent prostate‐specific antigen era: Implications for unilateral ablative therapy , 2008, The Prostate.

[13]  Athanase Billis,et al.  The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies. , 2008, The Journal of urology.

[14]  L. Egevad.  Recent trends in Gleason grading of prostate cancer: I. Pattern interpretation. , 2008, Analytical and quantitative cytology and histology.

[15]  A. Partin,et al.  Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma. , 2008, The Journal of urology.

[16]  L. Egevad,et al.  Correlation of modified Gleason grading of prostate carcinoma with age, serum prostate specific antigen and tumor extent in needle biopsy specimens. , 2008, Analytical and quantitative cytology and histology.

[17]  D. Bostwick,et al.  Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer. , 2008, Urology.

[18]  L. Egevad,et al.  Correlation of modified Gleason grading with pT stage of prostatic carcinoma after radical prostatectomy. , 2008, Analytical and quantitative cytology and histology.

[19]  Oliver Sartor,et al.  Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. , 2007, The Journal of urology.

[20]  M. Rubin,et al.  TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. , 2007, Urology.

[21]  P. Pierorazio,et al.  Outcome after cytoreductive nephrectomy for metastatic renal cell carcinoma is predicted by fractional percentage of tumour volume removed , 2007, BJU international.

[22]  P. Pierorazio,et al.  High‐grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy , 2007, BJU international.

[23]  J. Jones,et al.  Focal or Subtotal Therapy for Early Stage Prostate Cancer , 2007, Current treatment options in oncology.

[24]  J. Moul,et al.  Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer , 2007, Cancer.

[25]  Liang Cheng,et al.  Bladder cancer: epidemiology, staging and grading, and diagnosis. , 2005, Urology.

[26]  John Boyages,et al.  Multifocal and multicentric breast cancer: does each focus matter? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  L. Egevad,et al.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.

[28]  Liang Cheng,et al.  Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens , 2005, Modern Pathology.

[29]  Ferran Algaba,et al.  Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies , 2005, BJU international.

[30]  M. Dietlein,et al.  Incidental multifocal papillary microcarcinomas of the thyroid: Is subtotal thyroidectomy combined with radioiodine ablation enough? , 2005, Nuclear medicine communications.

[31]  Lang Li,et al.  Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate , 2004, Cancer.

[32]  T. Stamey,et al.  Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. , 2003, The Journal of urology.

[33]  J. Cheville,et al.  The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. , 2003, The Journal of urology.

[34]  A. Barrier,et al.  Early gastric carcinoma: spread and multicentricity , 2002, Gastric Cancer.

[35]  T. Stamey,et al.  Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. , 2002, Urology.

[36]  C. Windischberger,et al.  Spatial Distribution of Prostate Cancers Undetected on Initial Needle Biopsies , 2001, European Urology.

[37]  D. Johnston,et al.  Detailed mapping of prostate carcinoma foci , 2000, Cancer.

[38]  S. Egawa,et al.  Infrequent involvement of the anterior base in low-risk patients with clinically localized prostate cancer and its possible significance in definitive radiation therapy. , 2000, Japanese journal of clinical oncology.

[39]  J. Hanley,et al.  Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. , 1999, JAMA.

[40]  M. Banerjee,et al.  Racial differences and prognostic significance of tumor location in radical prostatectomy specimens , 1998, The Prostate.

[41]  D J Ruiter,et al.  HISTOLOGICAL GRADE HETEROGENEITY IN MULTIFOCAL PROSTATE CANCER. BIOLOGICAL AND CLINICAL IMPLICATIONS , 1996, The Journal of pathology.

[42]  A. Partin,et al.  Original Articles: Prostate Cancer , 1995 .

[43]  G. Miller,et al.  Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration. , 1994, The Journal of urology.

[44]  D. Bostwick,et al.  Staging of early prostate cancer: a proposed tumor volume-based prognostic index. , 1993, Urology.

[45]  T. Stamey,et al.  Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors , 1992, Cancer.

[46]  D P Byar,et al.  Carcinoma of the prostate: Prognostic evaluation of certain pathologic features in 208 radical prostatectomies , 1972 .

[47]  R. Giudicelli,et al.  Multifocal T4 non-small cell lung cancer: a subset with improved prognosis. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[48]  J. Presti,et al.  Prostate biopsy: current status and limitations. , 2007, Reviews in urology.

[49]  P. Walsh,et al.  Pathological features of hereditary prostate cancer. , 1995, The Journal of urology.